0001477449-24-000046.txt : 20240305
0001477449-24-000046.hdr.sgml : 20240305
20240305161016
ACCESSION NUMBER: 0001477449-24-000046
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Verstraete Stephany
CENTRAL INDEX KEY: 0001726419
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 24720412
MAIL ADDRESS:
STREET 1: C/O TELADOC, INC.
STREET 2: 2 MANHATTANVILLE ROAD, SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
wk-form4_1709672996.xml
FORM 4
X0508
4
2024-03-01
0
0001477449
Teladoc Health, Inc.
TDOC
0001726419
Verstraete Stephany
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
CHIEF MARKETING OFFICER
0
Common Stock
2024-03-01
4
M
0
4437
A
47554
D
Common Stock
2024-03-01
4
M
0
437
A
47991
D
Common Stock
2024-03-01
4
M
0
867
A
48858
D
Common Stock
2024-03-01
4
M
0
1404
A
50262
D
Common Stock
2024-03-01
4
M
0
13021
A
63283
D
Common Stock
2024-03-01
4
M
0
1148
A
64431
D
Common Stock
2024-03-04
4
S
0
7945
14.516
D
56486
D
Performance Stock Units
2024-03-01
4
A
0
13313
0
A
Common Stock
13313
13313
D
Performance Stock Units
2024-03-01
4
M
0
4437
0
D
Common Stock
4437
8876
D
Performance Stock Units
2024-03-01
4
M
0
437
0
D
Common Stock
437
0
D
Performance Stock Units
2024-03-01
4
M
0
867
0
D
Common Stock
867
0
D
Restricted Stock Units
2024-03-01
4
M
0
1404
0
D
Common Stock
1404
5616
D
Restricted Stock Units
2024-03-01
4
M
0
13021
0
D
Common Stock
13021
26042
D
Restricted Stock Units
2024-03-01
4
M
0
1148
0
D
Common Stock
1148
0
D
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 1, 2024, the reporting person earned 13,313 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 2, 2023, the reporting person earned 874 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
On March 2, 2022, the reporting person earned 2,602 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
On March 1, 2022, the reporting person was granted 16,844 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 3, 2023, the reporting person was granted 39,063 restricted stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 2, 2021, the reporting person was granted 3,442 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2024-03-05